Quick Hits: E-Cigs and Heart Attacks, Influencing Doctor Prescribing & More

Quick Hits: Transvaginal Mesh Pulled, New Weight Loss Drug & More

Using e-cigarettes daily can significantly increase a person’s risk of having a heart attack. Researchers analyzed responses from almost 70,000 people that took part in the National Health Interview Survey. About 3.6% of current and former e-cigarette users reported having a heart attack, and 6.1% of those who used an e-cigarette daily had a heart attack. People that said they used both conventional cigarettes and an e-cigarette every day were 4.6 times more likely to have a heart attack than those who had not used either product. Posted August 22, 2018. Via American Journal of Preventive Medicine.

Writing letters to physicians that prescribe more of a drug than other doctors may help them cut down on those prescriptions. A study examined prescriptions for the antipsychotic drug Seroquel (quetiapine). The Centers for Medicaid and Medicare Services sent letters to about 5,000 doctors that had written the most Seroquel prescriptions. The letter said that they wrote many more prescriptions for the drug than the average for their state, and included a statement that they had been “flagged as a markedly unusual prescriber.” After following the doctors’ Seroquel prescribing for the next 2 years, researchers found that the prescriptions declined by 16%. Posted August 1, 2018. Via JAMA Psychiatry.

The FDA has approved the first generic version of EpiPen, an epinephrine-containing injection used for emergency treatment of allergic reactions. The approval comes as there is a nationwide shortage of the auto-injector. Mylan, the pharmaceutical company that sells the EpiPen brand version, has been heavily criticized for drastically increasing the price of the product. One pen used to cost $50. A 2-pen set now costs around $600. Last year, the FDA reported at least 7 deaths linked to EpiPens that failed to deploy properly. Posted August 16, 2018. Via FDA.


Jonathan Block

Jonathan Block

Jonathan Block is an associate editor at BioCentury, which provides news and information about the biotechnology and pharmaceutical industries. Prior to joining BioCentury in 2019, Jonathan worked for MedShadow as content editor. He has been an editor and writer for multiple pharmaceutical, health and medical publications, including The Pink Sheet, Modern Healthcare, Health Plan Week and Psychiatry Advisor. He holds a BA from Tufts University and is earning an MPH with a focus on health policy from the CUNY Graduate School of Public Health & Health Policy.


Did you find this article helpful?


Latest News

Breaking News – EpiPen Malfunction

Breaking News – EpiPen Malfunction

Just released from the FDA – Pfizer has informed the FDA that they are aware of several continuing problems that people are having using the EpiPen (epinephrine) and EpiPen Jr (epinephrine) auto-injectors and generic versions. Some of the problems are from user error and some from EpiPen malfunction. Here are…

ACE Inhibitors in the Time of Coronavirus

ACE Inhibitors in the Time of Coronavirus

Are you worried about ACE inhibitors and coronavirus? You may be hearing that one of the entry methods for the coronavirus in humans is by attaching to the ACE-2 enzyme. This has raised alarms among those with heart disease who use ACE inhibitors (with names ending in -pril, such as…

  • Advertisement